| Date Filed | Type | Description |
| 05/09/2023 |
4
| REESE DAVID M (EVP, Research and Development) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 594 shares
@ $231.89, valued at
$137.7k
|
|
| 05/04/2023 |
4
| REESE DAVID M (EVP, Research and Development) has filed a Form 4 on AMGEN INC|
Txns:
| Granted 3,814 shares
@ $0
Paid exercise price by delivering 819 shares
@ $235.97, valued at
$193.3k
Granted 32,250 options to buy
@ $235.97, valued at
$7.6M
|
|
| 05/02/2023 |
4
| REESE DAVID M (EVP, Research and Development) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 666 shares
@ $239.74, valued at
$159.7k
|
|
| 03/20/2023 |
4
| REESE DAVID M (EVP, Research and Development) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 3,978 shares
@ $234.57, valued at
$933.1k
|
|
| 03/08/2023 |
4
| REESE DAVID M (EVP, Research and Development) has filed a Form 4 on AMGEN INC|
Txns:
| Granted 7,947 shares
@ $0 |
|
| 11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2022 |
4
| REESE DAVID M (EVP, Research and Development) has filed a Form 4 on AMGEN INC|
Txns:
| Granted 3,897 shares
@ $0
Paid exercise price by delivering 770 shares
@ $230.92, valued at
$177.8k
Granted 31,817 options to buy
@ $230.92, valued at
$7.3M
|
|
| 04/29/2022 |
4
| REESE DAVID M (EVP, Research and Development) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 184 shares
@ $249.87, valued at
$46k
|
|
| 03/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2021 |
4
| REESE DAVID M (EVP, Research and Development) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 2,192 shares
@ $209.74, valued at
$459.8k
|
|
| 05/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/04/2020 |
4
| REESE DAVID M (EVP, Research and Development) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 2,125 shares
@ $216.94, valued at
$461k
|
|
| 05/07/2020 |
4
| REESE DAVID M (EVP, Research and Development) has filed a Form 4 on AMGEN INC|
Txns:
| Granted 3,469 shares
@ $0
Granted 29,050 options to buy
@ $236.36, valued at
$6.9M
|
|
| 05/05/2020 |
4
| REESE DAVID M (EVP, Research and Development) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 1,046 shares
@ $239.22, valued at
$250.2k
Paid exercise price by delivering 185 shares
@ $230.98, valued at
$42.7k
|
|
| 04/29/2020 |
4
| REESE DAVID M (EVP, Research and Development) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 168 shares
@ $236.28, valued at
$39.7k
|
|
| 03/24/2020 |
4
| REESE DAVID M (EVP, Research and Development) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 1,855 shares
@ $198.76, valued at
$368.7k
|
|
| 03/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/07/2019 |
4
| REESE DAVID M (EVP, Research and Development) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 174 shares
@ $176.5, valued at
$30.7k
Granted 4,511 shares
@ $0
Granted 39,382 options to buy
@ $177.31, valued at
$7M
|
|
| 05/03/2019 |
4
| REESE DAVID M (EVP, Research and Development) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 163 shares
@ $179.3232, valued at
$29.2k
Paid exercise price by delivering 851 shares
@ $179.3232, valued at
$152.6k
|
|
| 03/25/2019 |
4
| REESE DAVID M (EVP, Research and Development) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 1,769 shares
@ $191.89, valued at
$339.5k
|
|
| 03/08/2019 |
4
| REESE DAVID M (EVP, Research and Development) has filed a Form 4 on AMGEN INC|
Txns:
| Granted 3,676 shares
@ $0 |
|
| 02/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/06/2018 |
4
| REESE DAVID M (EVP, Research and Development) has filed a Form 4 on AMGEN INC|
Txns:
| Granted 12,830 shares
@ $0 |
|
| 08/02/2018 |
3
| REESE DAVID M (EVP, Research and Development) has filed a Form 3 on AMGEN INC |